Class Action Lawsuit Overview - A class action lawsuit has been filed against Walgreens Boots Alliance Inc (WBA) on behalf of purchasers of its common stock between July 1 2021 and June 26 2024 [1] - Investors have until November 18 2024 to seek appointment as lead plaintiff in the lawsuit [1] Walgreens Business Operations - Walgreens operates in three business segments: US Retail Pharmacy International and US Healthcare [3] - In 2019 Walgreens announced a collaboration with VillageMD involving a $1 billion investment and expansion of primary care facilities next to Walgreens stores [3] Lawsuit Allegations - Walgreens allegedly inefficiently deployed capital meant to grow its US Healthcare segment and failed to properly implement its partnership with VillageMD [4] - The company was unable to profitably scale VillageMD and its rollout of clinics did not proceed as planned [4] - Walgreens built too many VillageMD clinics leading to understaffing and fewer patients which slowed the growth of its US Healthcare segment [4] - Executives failed to manage investor expectations about the negative impact of the VillageMD rollout on short-term profits and exaggerated VillageMD's value [4] Financial Performance and Stock Price Impact - On June 27 2023 Walgreens announced disappointing earnings for fiscal Q3 2023 reduced 2023 guidance and revealed slower profit ramp for US Healthcare due to VillageMD's underperformance causing a $2 95 (9 3%) drop in stock price [5] - On July 27 2023 the departure of the CFO caused a $0 83 (nearly 3%) drop in stock price [5] - On September 1 2023 the departure of the CEO caused a $1 88 (7 4%) drop in stock price [5] - On January 4 2024 disappointing fiscal Q1 2024 results attributed to VillageMD operations caused a $1 31 (5%) drop in stock price [6] - On June 27 2024 disappointing fiscal Q3 2024 results and announcement of reducing stake in VillageMD caused a $3 47 (22%) drop in stock price [6] Legal Representation - DiCello Levitt is handling the class action lawsuit and has achieved top recognition as Plaintiffs Firm of the Year and Trial Innovation Firm of the Year [7][8]

The most recent trading session ended with Walgreens Boots Alliance (WBA) standing at $9.01, reflecting a -0.55% shift from the previouse trading day's closing. The stock trailed the S&P 500, which registered a daily loss of 0.29%. At the same time, the Dow lost 0.25%, and the tech-heavy Nasdaq lost 0.31%.Coming into today, shares of the largest U.S. drugstore chain had lost 15.56% in the past month. In that same time, the Retail-Wholesale sector gained 4.15%, while the S&P 500 gained 1.57%.Investors will b ...

BOCA RATON, Fla., Sept. 17, 2024 (GLOBE NEWSWIRE) -- Saxena White P.A. has filed a securities fraud class action lawsuit (the “Class Action”) in the United States District Court for the Northern District of Illinois against Walgreens Boots Alliance, Inc. (“Walgreens” or the “Company”) (NASDAQ: WBA) and certain of its executive officers (collectively, “Defendants”). The Class Action asserts claims under Sections 10(b) and 20(a) of the Securities and Exchange Act of 1934 (the “Exchange Act”) and U.S. Securiti ...

NEW YORK, Sept. 16, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Walgreens Boots Alliance, Inc. (NASDAQ: WBA) on behalf of long-term stockholders following a class action complaint that was filed against Walgreens on July 12, 2024 with a Class Period from October 12, 2023 to June 26, 2024. Our investigation concerns whether the board of directors of Walgreens have breached their fiduciary duties to the co ...

It could be smaller, but more financially sustainable if things go as planned.While you've probably had a consistent experience going to the pharmacies operated by Walgreens Boots Alliance (WBA 4.19%) over the years, that doesn't make it a company that's in stasis. In fact, within the next three years, there's a very high chance that it'll be changing in a handful of ways that are relevant to investors.But even if the retail experience doesn't shift much, there's reason to believe that the stock's value wil ...

Its challenges are formidable, so only certain investors should consider it.As the great investor Peter Lynch once suggested, investing in companies that you know well and interact with every day can be a great way to exercise an edge and make a profit. But that doesn't mean you should invest in every company you know well.On that note, Walgreens Boots Alliance (WBA 4.19%) is a business that many of us are customers of, and often for many years. Yet it probably isn't the best choice for investors who prefer ...

Investors can contact the law firm at no cost to learn more about recovering their losses LOS ANGELES, Sept. 11, 2024 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Walgreens Boots Alliance, Inc. ("Walgreens" or the "Company") (NASDAQ: WBA) investors of a class action representing investors that bought securities between October 12, 2023 to June 26, 2024, inclusive (the "Class Period"). Walgreens investors have until September 10, 2024 to file a lead plaintiff motion. Investors are encouraged to contact a ...

Walgreens Boots Alliance, Inc. (NASDAQ:WBA) TD Cowen 9th Annual FutureHealth Conference September 10, 2024 4:10 PM ET Company Participants Ramita Tandon - Chief Clinical Trial Officer Conference Call Participants Charles Rhyee - TD Cowen Charles Rhyee All right. I think, we're going to get started with our last session of the day, and thanks everyone for sticking around here. So, in June of '22, Walgreens launched its clinical trial business, which utilizes Walgreens national retail pharmacy footprint to pr ...

Walgreens Boots Alliance, Inc. (NASDAQ:WBA) TD Cowen 9th Annual FutureHealth Conference September 10, 2024 4:10 PM ET Company Participants Ramita Tandon - Chief Clinical Trial Officer Conference Call Participants Charles Rhyee - TD Cowen Charles Rhyee All right. I think, we're going to get started with our last session of the day, and thanks everyone for sticking around here. So, in June of '22, Walgreens launched its clinical trial business, which utilizes Walgreens national retail pharmacy footprint to pr ...

NEW YORK, Sept. 10, 2024 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareholders of Walgreens Boots Alliance, Inc. (NASDAQ: WBA). Shareholders who purchased shares of WBA during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery. CONTACT US HERE: https://securitiesclasslaw.com/securities/walgreens-boots-alliance-inc-loss-submission-form/?id=101231&from=3 ...